While IFN-γ appears to be a possible marker of treatment response and IFN-λ3 selectively identifies severe disease stages, soluble HVEM and bacterial translocation would thus appear to be features of all stages of PBC. Here, TNFRSF14 is linked to primary biliary cholangitis.